NCT03338387View on ClinicalTrials.gov

Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia

PHASE2Enrolling by invitationINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

May 6, 2003

Primary Completion Date

December 16, 2007

Study Completion Date

December 20, 2026

Conditions

Eating DisorderBulimia Nervosa

Interventions

DRUG

Acipimox

Acipimox

DRUG

Placebo

Placebo Other Names: Placebo (for Olbetam)

All Listed Sponsors

lead

Charles University, Czech Republic

OTHER